Clinical Documentation

Published placebo controlled clinical trials and pilot trials, with more than 1,000 patients, have documented the efficacy of Ecovag® OTC Vaginal Capsule in improving several aspects of vaginal health;

Significantly reduction of recurrent bacterial vaginosis (BV) infections, when used in combination with antibiotics

Significantly higher colonization of Ecovag® strains in BV-cured patients

Fast and effective elimination of vaginal discomfort in women diagnosed with BV

Longterm cure against BV when used in combination with antibiotics

Improved longterm cure against recurrent vulovaginal candidiasis, when used in combination with antifungal medication

Fast and effective relief of vaginal infection symptoms in women seeking medical help for vaginal discomfort

Proven safety and convenience of use

Bifodan maintains a pipeline of on-going clinical trials that are expected to be published in the coming period and will contribute to further substantiate the efficacy of Ecovag®


This section is intended for B2B purposes. Please check the box if applicable.

No, I am a private consumer